Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001214659-24-006037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-04-03 | 2024-04-01 | ALZN | AULT MILTON C III | Dir, 10% | P - Purchase | $0.91 | +334 | 770.7K | +0.0% | +$303.94 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | P | A | 334 | $0.91 | 770,699 | I By Ault Lending, LLC | — | — | (F1) Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |